307 related articles for article (PubMed ID: 32180772)
21. Alterations in the metabolism of tryptophan in patients with chronic hepatitis C six months after pegylated interferon-α 2a treatment.
Pawlowski T; Malyszczak K; Inglot M; Zalewska M; Radkowski M; Laskus T; Pawlak D
Psychoneuroendocrinology; 2018 Nov; 97():1-7. PubMed ID: 29990677
[TBL] [Abstract][Full Text] [Related]
22. Tryptophan Pathway Abnormalities in a Murine Model of Hereditary Glaucoma.
Fiedorowicz M; Choragiewicz T; Turski WA; Kocki T; Nowakowska D; Wertejuk K; Kamińska A; Avitabile T; Wełniak-Kaminska M; Grieb P; Zweifel S; Rejdak R; Toro MD
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494373
[TBL] [Abstract][Full Text] [Related]
23. Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: The role of immune activation.
Mechtcheriakov S; Gleissenthall GV; Geisler S; Arnhard K; Oberacher H; Schurr T; Kemmler G; Unterberger C; Fuchs D
Alcohol Clin Exp Res; 2022 Sep; 46(9):1648-1656. PubMed ID: 35938556
[TBL] [Abstract][Full Text] [Related]
24. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
[TBL] [Abstract][Full Text] [Related]
25. Canine mast cell tumour cells regulate tryptophan catabolism via the expression of indoleamine 2,3-dioxygenase.
Matsuda A; Hata A; Tanaka A; Matsuda H
Res Vet Sci; 2021 Jul; 137():159-162. PubMed ID: 33984619
[TBL] [Abstract][Full Text] [Related]
26. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing.
Ito H; Ando T; Ogiso H; Arioka Y; Saito K; Seishima M
Biomaterials; 2015 Jun; 53():221-8. PubMed ID: 25890721
[TBL] [Abstract][Full Text] [Related]
28. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
[TBL] [Abstract][Full Text] [Related]
29. Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model.
Wirthgen E; Tuchscherer M; Otten W; Domanska G; Wollenhaupt K; Tuchscherer A; Kanitz E
Innate Immun; 2014 Jan; 20(1):30-9. PubMed ID: 23606516
[TBL] [Abstract][Full Text] [Related]
30. DSS-induced acute colitis causes dysregulated tryptophan metabolism in brain: an involvement of gut microbiota.
Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Ting-Li ; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
J Nutr Biochem; 2023 May; 115():109282. PubMed ID: 36758839
[TBL] [Abstract][Full Text] [Related]
31. Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest.
Schefold JC; Fritschi N; Fusch G; Bahonjic A; Doehner W; von Haehling S; Pschowski R; Storm C; Schroeder T
Resuscitation; 2016 Oct; 107():107-14. PubMed ID: 27565863
[TBL] [Abstract][Full Text] [Related]
32. Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
Schefold JC; Zeden JP; Pschowski R; Hammoud B; Fotopoulou C; Hasper D; Fusch G; Von Haehling S; Volk HD; Meisel C; Schütt C; Reinke P
Scand J Infect Dis; 2010 Mar; 42(3):164-71. PubMed ID: 19958238
[TBL] [Abstract][Full Text] [Related]
33. Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway.
Jand Y; Ghahremani MH; Ghanbari A; Ejtemaei-Mehr S; Guillemin GJ; Ghazi-Khansari M
Sci Rep; 2022 Sep; 12(1):15963. PubMed ID: 36153399
[TBL] [Abstract][Full Text] [Related]
34. 1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
Liu X; Zhou W; Zhang X; Ding Y; Du Q; Hu R
Int J Cancer; 2018 Sep; 143(6):1516-1529. PubMed ID: 29607498
[TBL] [Abstract][Full Text] [Related]
35. Target exposure and pharmacodynamics study of the indoleamine 2,3-dioxygenase-1 (IDO-1) inhibitor epacadostat in the CT26 mouse tumor model.
Poncelet L; Ait-Belkacem R; Marillier R; Gomes B; Stauber J
J Pharm Biomed Anal; 2019 Jun; 170():220-227. PubMed ID: 30933897
[TBL] [Abstract][Full Text] [Related]
36. Genetic Deficiency of Indoleamine 2,3-dioxygenase Aggravates Vascular but Not Liver Disease in a Nonalcoholic Steatohepatitis and Atherosclerosis Comorbidity Model.
Arora A; Tripodi GL; Kareinen I; Berg M; Forteza MJ; Gisterå A; Griepke S; Casagrande FB; Martins JO; Abdalla DSP; Cole J; Monaco C; Ketelhuth DFJ
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563591
[TBL] [Abstract][Full Text] [Related]
37. Impaired kynurenine metabolism in patients with primary Sjögren's syndrome.
Eryavuz Onmaz D; Tezcan D; Abusoglu S; Sak F; Humeyra Yerlikaya F; Yilmaz S; Abusoglu G; Kazim Korez M; Unlu A
Clin Biochem; 2023 Apr; 114():1-10. PubMed ID: 36681140
[TBL] [Abstract][Full Text] [Related]
38. Extension of life span by down-regulation of enzymes catalyzing tryptophan conversion into kynurenine: Possible implications for mechanisms of aging.
Oxenkrug G; Navrotska V
Exp Biol Med (Maywood); 2023 Apr; 248(7):573-577. PubMed ID: 37300401
[TBL] [Abstract][Full Text] [Related]
39. Quantification of IDO1 enzyme activity in normal and malignant tissues.
Zhai L; Ladomersky E; Bell A; Dussold C; Cardoza K; Qian J; Lauing KL; Wainwright DA
Methods Enzymol; 2019; 629():235-256. PubMed ID: 31727243
[TBL] [Abstract][Full Text] [Related]
40. Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma.
Rad Pour S; Morikawa H; Kiani NA; Yang M; Azimi A; Shafi G; Shang M; Baumgartner R; Ketelhuth DFJ; Kamleh MA; Wheelock CE; Lundqvist A; Hansson J; Tegnér J
Sci Rep; 2019 Aug; 9(1):12150. PubMed ID: 31434983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
